FDA reclassification of Rapid Antigen flu testing

August 10, 2017

 

FDA reclassification of rapid flu antigen testing

Please join Frederick S. Nolte, Ph.D., D(ABMM), F(AAM), Professor and Vice Chair for Laboratory Medicine in the Department of Pathology and Laboratory Medicine, and Medical Director of Clinical Laboratories, Molecular Pathology Laboratory and Point-Care-Testing at the Medical University of South Carolina, as he shares his insight regarding the recent FDA reclassification of Rapid Antigen flu testing, and why it's an opportunity for lab leadership.

 

Previous Article
A New Year's Resolution: Become a Better Antibiotic Steward
A New Year's Resolution: Become a Better Antibiotic Steward

Please join Amesh Adalja, MD, FACP, Senior Associate, UPMC Center for Health Security, as he outlines what ...

Next Article
Unveiling the Future of Laboratory Medicine
Unveiling the Future of Laboratory Medicine

×

LabLeaders.com has a new home. Tell us a bit about yourself.

Thank you!
Error - something went wrong!